Qihan Biotechnology Co. Ltd.

Chinese biotechs saw the pace of fundraising backed by venture capital and private equity firms slow down in September. Createrna Science and Technology bagged the largest cash injection of CNY500m ($

Biopharmaceutical companies raised $1.5bn in 11 venture capital mega-rounds of $100m or more during the last week and a half of March. Including VC and other financings under $100m, 35 privately held